Pyxis Oncology Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pyxis Oncology Inc
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
/ 
Frequently asked questions
To buy Pyxis Oncology Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pyxis Oncology Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pyxis Oncology Inc is PYXS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pyxis Oncology Inc has its primary listing on NASDAQ. You can trade Pyxis Oncology Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pyxis Oncology Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pyxis Oncology Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pyxis Oncology Inc.